Table 3.
Prospective association of baseline psychopathology (t) with metabolic syndrome components at the next assessment (t + 1)
| 0→2 Years | 2→6 Years | ||||||
|---|---|---|---|---|---|---|---|
| Predictor (t) | Outcome (t + 1) | B | SE | P | B | SE | P |
| IDS | Number of components | 0.0027 | 0.0010 | .006 | −0.0009 | 0.0013 | .513 |
| BAI | Number of components | 0.0030 | 0.0013 | .026 | −0.0006 | 0.0018 | .758 |
| Antidepressant use (vs. none) | Number of components | 0.0731 | 0.0308 | .017 | 0.0086 | 0.0378 | .820 |
| IDS | Waist | 0.0251 | 0.0103 | .015 | −0.0003 | 0.0159 | .985 |
| BAI | Waist | 0.0293 | 0.0142 | .039 | −0.0030 | 0.0232 | .898 |
| Antidepressant use (vs. none) | Waist | 1.2098 | 0.3120 | <.001 | −1.4736 | 0.4298 | .001 |
| IDS | HDL | −0.0008 | 0.0004 | .032 | 0.0001 | 0.0006 | .843 |
| BAI | HDL | −0.0008 | 0.0005 | .137 | −0.0002 | 0.0008 | .837 |
| Antidepressant use (vs. none) | HDL | −0.0147 | 0.0123 | .229 | −0.0067 | 0.0165 | .685 |
| IDS | Triglycerides | 0.0004 | 0.0003 | .133 | 0.0004 | 0.0004 | .279 |
| BAI | Triglycerides | 0.0005 | 0.0004 | .151 | 0.0008 | 0.0005 | .137 |
| Antidepressant use (vs. none) | Triglycerides | 0.0272 | 0.0086 | .002 | 0.0169 | 0.0108 | .119 |
| IDS | SBP | −0.0121 | 0.0189 | .523 | 0.0024 | 0.0267 | .928 |
| BAI | SBP | −0.0251 | 0.0277 | .365 | 0.0300 | 0.0381 | .431 |
| Antidepressant use (vs. none) | SBP | 0.4676 | 0.6468 | .470 | −0.2191 | 0.7495 | .770 |
| IDS | Glucose | 0.0000 | 0.0001 | .598 | 0.0002 | 0.0001 | .153 |
| BAI | Glucose | 0.0000 | 0.0001 | .850 | 0.0002 | 0.0002 | .195 |
| Antidepressant use (vs. none) | Glucose | 0.0095 | 0.0026 | <.001 | −0.0007 | 0.0028 | .800 |
Estimates were obtained from generalized estimating equations. Analyses were adjusted for baseline values of the outcome, age, sex, education, smoking, alcohol use, and physical activity.